As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support ...
The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying.
A marathon runner has said a prostate cancer test would have saved him from his terminal diagnosis. Tony Collier, 68, who has ...
The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny ...
Freenome is taking itself public via a special purpose acquisition company, also known as a SPAC deal, to help raise funds in ...
Dave Santee said he decided to take the Galleri test, a blood test that analyzes a person’s blood for DNA of cancer cells, ...
A cancer diagnosis is never welcome news. But for certain types of cancers, a doctor’s confirmation can be a lifesaver.
Morning Overview on MSNOpinion
Promising cancer blood test masks a critical weakness
Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood ...
A major breakthrough has been made that a simple blood test analyzed by artificial intelligence could allow for early ...
Natera is looking to grow its portfolio of tools to detect the recurrence of cancer with a deal to acquire Foresight ...
A novel blood test analyzing fragments of cell-free DNA showed robust diagnostic performance for colorectal cancer across clinical subgroups, offering a promising noninvasive screening method.
Money Talks News on MSN
A simple blood test claims to detect 50 cancers but FDA approval remains uncertain
A new blood test analyzes DNA fragments to screen for 50 types of cancer simultaneously. The $949 Galleri test detected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results